Sanofi, Novo back a small biotech that's neck and neck with Pfizer to develop a Group B streptococcus vaccine
Per Fischer is used to going into meetings with Big Pharma — usually surrounded by 20 to 30 people on their vaccine development teams — alone. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
